Rationally designed tumor-penetrating nanocomplexes

ACS Nano

Volumn 6, Issue 10, 2012, Pages 8484-8487

  Karagiannis, Emmanouil D ^a   Alabi, Christopher A ^a,b   Anderson, Daniel G ^a,b,c  

^a David H Koch Institute for Integrative Cancer Research   (United States)

^b Massachusetts Institute of Technology Cambridge   (United States)

^c HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACES; COMPUTATIONAL APPROACH; COMPUTATIONAL MODELING; DELIVERY SYSTEMS; DELIVERY VEHICLE; GENE SILENCING; IN-VIVO; INTRACELLULAR COMPARTMENTS; MULTIPLE COMPONENTS; NANOCOMPLEXES; OVARIAN CANCERS; SERUM PROTEINS; SMALL INTERFERING RNA (SIRNA); TARGET TISSUES; TUMOR CELL LINES;

CELL CULTURE; CELL MEMBRANES; GENETIC ENGINEERING; PEPTIDES; RNA;

TUMORS;

CELL SURFACE RECEPTOR; NANOCAPSULE; PEPTIDE; SMALL INTERFERING RNA;

EXPERIMENTAL NEOPLASM; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; METHODOLOGY; NOTE; PATHOPHYSIOLOGY;

HUMANS; NANOCAPSULES; NEOPLASMS, EXPERIMENTAL; PEPTIDES; RECEPTORS, CELL SURFACE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84867751685     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn304707b     Document Type: Review

References (18)

1. Butcher, E. C.; Berg, E. L.; Kunkel, E. J. Systems Biology in Drug Discovery Nat. Biotechnol. 2004, 22, 1253-1259 (Pubitemid 39336778)
2. Whitehead, K. A.; Langer, R.; Anderson, D. G. Knocking Down Barriers: Advances in siRNA Delivery Nat. Rev. Drug Discovery 2009, 8, 129-138
3. King, N. P.; Sheffler, W.; Sawaya, M. R.; Vollmar, B. S.; Sumida, J. P.; Andre, I.; Gonen, T.; Yeates, T. O.; Baker, D. Computational Design of Self-Assembling Protein Nanomaterials with Atomic Level Accuracy Science 2012, 336, 1171-1174
4. Schrattenholz, A.; Groebe, K.; Soskic, V. Systems Biology Approaches and Tools for Analysis of Interactomes and Multi-Target Drugs Methods Mol. Biol. 2010, 662, 29-58
5. Karagiannis, E. D.; Popel, A. S. A Systematic Methodology for Proteome-Wide Identification of Peptides Inhibiting the Proliferation and Migration of Endothelial Cells Proc. Natl. Acad. Sci. U.S.A. 2008, 105, 13775-13780
6. Lindgren, M.; Hallbrink, M.; Prochiantz, A.; Langel, U. Cell-Penetrating Peptides Trends Pharmacol. Sci. 2000, 21, 99-103 (Pubitemid 30114324)
7. Lindgren, M.; Langel, U. Classes and Prediction of Cell-Penetrating Peptides Methods Mol. Biol. 2011, 683, 3-19
8. Snyder, E. L.; Dowdy, S. F. Cell Penetrating Peptides in Drug Delivery Pharm. Res. 2004, 21, 389-393 (Pubitemid 38338971)
9. Almeida, P. F.; Pokorny, A. Mechanisms of Antimicrobial, Cytolytic, and Cell-Penetrating Peptides: From Kinetics to Thermodynamics Biochemistry 2009, 48, 8083-8093
10. Kim, H. K.; Davaa, E.; Myung, C. S.; Park, J. S. Enhanced siRNA Delivery Using Cationic Liposomes with New Polyarginine-Conjugated PEG-Lipid Int. J. Pharm. 2010, 392, 141-147
11. Inoue, Y.; Kurihara, R.; Tsuchida, A.; Hasegawa, M.; Nagashima, T.; Mori, T.; Niidome, T.; Katayama, Y.; Okitsu, O. Efficient Delivery of siRNA Using Dendritic Poly(l -lysine) for Loss-of-Function Analysis J. Controlled Release 2008, 126, 59-66 (Pubitemid 351163418)
12. Zorko, M.; Langel, U. Cell-Penetrating Peptides: Mechanism and Kinetics of Cargo Delivery Adv. Drug Delivery Rev. 2005, 57, 529-545 (Pubitemid 40255559)
13. van den Berg, A.; Dowdy, S. F. Protein Transduction Domain Delivery of Therapeutic Macromolecules Curr. Opin. Biotechnol. 2011, 22, 888-893
14. Ren, Y.; Hauert, S.; Lo, J. H.; Bhatia, S. N. Identification and Characterization of Receptor-Specific Peptides for siRNA Delivery ACS Nano 2012, 10.1021/nn301975s
15. Laakkonen, P.; Porkka, K.; Hoffman, J. A.; Ruoslahti, E. A Tumor-Homing Peptide with a Targeting Specificity Related to Lymphatic Vessels Nat. Med. 2002, 8, 751-755 (Pubitemid 34778730)
16. Ren, Y.; Cheung, H. W.; von Maltzhan, G.; Agrawal, A.; Cowley, G. S.; Weir, B. A.; Boehm, J. S.; Tamayo, P.; Karst, A. M.; Liu, J. F. et al. Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4 Sci. Transl. Med. 2012, 4, 147ra112
17. Nijhawan, D.; Zack, T. I.; Ren, Y.; Strickland, M. R.; Lamothe, R.; Schumacher, S. E.; Tsherniak, A.; Besche, H. C.; Rosenbluh, J.; Shehata, S. et al. Cancer Vulnerabilities Unveiled by Genomic Loss Cell 2012, 150, 842-854
18. Decuzzi, P.; Ferrari, M. Design Maps for Nanoparticles Targeting the Diseased Microvasculature Biomaterials 2008, 29, 377-384 (Pubitemid 350081047)